255 related articles for article (PubMed ID: 9005987)
21. Molecular cytogenetic aberrations in autosomal dominant polycystic kidney disease tissue.
Gogusev J; Murakami I; Doussau M; Telvi L; Stojkoski A; Lesavre P; Droz D
J Am Soc Nephrol; 2003 Feb; 14(2):359-66. PubMed ID: 12538736
[TBL] [Abstract][Full Text] [Related]
22. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction.
Nauli SM; Rossetti S; Kolb RJ; Alenghat FJ; Consugar MB; Harris PC; Ingber DE; Loghman-Adham M; Zhou J
J Am Soc Nephrol; 2006 Apr; 17(4):1015-25. PubMed ID: 16565258
[TBL] [Abstract][Full Text] [Related]
23. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
24. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
[TBL] [Abstract][Full Text] [Related]
25. [Autosomal dominant polycystic kidney disease: detection of a new mutation in the PKD1 gene].
Iglesias DM; Manrique M; Arrizurieta EE; Kornblihtt AR; Herrera M; Martín RS; Bernath VA
Medicina (B Aires); 1999; 59(2):133-7. PubMed ID: 10413889
[TBL] [Abstract][Full Text] [Related]
26. Autosomal dominant polycystic kidney disease: molecular analysis.
Harris PC; Ward CJ; Peral B; Hughes J
Hum Mol Genet; 1995; 4 Spec No():1745-9. PubMed ID: 8541874
[TBL] [Abstract][Full Text] [Related]
27. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation.
Nishio S; Hatano M; Nagata M; Horie S; Koike T; Tokuhisa T; Mochizuki T
J Clin Invest; 2005 Apr; 115(4):910-8. PubMed ID: 15761494
[TBL] [Abstract][Full Text] [Related]
28. DNA microsatellite analysis of families with autosomal dominant polycystic kidney disease types 1 and 2: evaluation of clinical heterogeneity between both forms of the disease.
Coto E; Sanz de Castro S; Aguado S; Alvarez J; Arias M; Menéndez MJ; López-Larrea C
J Med Genet; 1995 Jun; 32(6):442-5. PubMed ID: 7666395
[TBL] [Abstract][Full Text] [Related]
29. Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease.
Koptides M; Mean R; Demetriou K; Pierides A; Deltas CC
Hum Mol Genet; 2000 Feb; 9(3):447-52. PubMed ID: 10655555
[TBL] [Abstract][Full Text] [Related]
30. Feline polycystic kidney disease mutation identified in PKD1.
Lyons LA; Biller DS; Erdman CA; Lipinski MJ; Young AE; Roe BA; Qin B; Grahn RA
J Am Soc Nephrol; 2004 Oct; 15(10):2548-55. PubMed ID: 15466259
[TBL] [Abstract][Full Text] [Related]
31. Type identification of autosomal dominant polycystic kidney disease by analysis of fluorescent short tandem repeat markers.
Lin WD; Wu JY; Tsai FJ; Gau MT; Lee CC
J Formos Med Assoc; 2002 Aug; 101(8):567-71. PubMed ID: 12440087
[TBL] [Abstract][Full Text] [Related]
32. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome.
Brook-Carter PT; Peral B; Ward CJ; Thompson P; Hughes J; Maheshwar MM; Nellist M; Gamble V; Harris PC; Sampson JR
Nat Genet; 1994 Dec; 8(4):328-32. PubMed ID: 7894481
[TBL] [Abstract][Full Text] [Related]
33. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
[TBL] [Abstract][Full Text] [Related]
34. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.
Lu W; Peissel B; Babakhanlou H; Pavlova A; Geng L; Fan X; Larson C; Brent G; Zhou J
Nat Genet; 1997 Oct; 17(2):179-81. PubMed ID: 9326937
[TBL] [Abstract][Full Text] [Related]
35. Autosomal dominant polycystic kidney disease: modification of disease progression.
Peters DJ; Breuning MH
Lancet; 2001 Oct; 358(9291):1439-44. PubMed ID: 11705510
[TBL] [Abstract][Full Text] [Related]
36. Screening the 3' region of the polycystic kidney disease 1 (PKD1) gene in 41 Bulgarian and Australian kindreds reveals a prevalence of protein truncating mutations.
Bogdanova N; McCluskey M; Sikmann K; Markoff A; Todorov V; Dimitrakov D; Schiavello T; Thomas M; Kalaydjieva L; Dworniczak B; Horst J
Hum Mutat; 2000; 16(2):166-74. PubMed ID: 10923038
[TBL] [Abstract][Full Text] [Related]
37. Polycystic kidney disease. 1: Identification and analysis of the primary defect.
Harris PC; Ward CJ; Peral B; Hughes J
J Am Soc Nephrol; 1995 Oct; 6(4):1125-33. PubMed ID: 8589278
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal evolution of the PKD1 gene family in primates.
Kirsch S; Pasantes J; Wolf A; Bogdanova N; Münch C; Markoff A; Pennekamp P; Krawczak M; Dworniczak B; Schempp W
BMC Evol Biol; 2008 Sep; 8():263. PubMed ID: 18822117
[TBL] [Abstract][Full Text] [Related]
39. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo.
Piontek KB; Huso DL; Grinberg A; Liu L; Bedja D; Zhao H; Gabrielson K; Qian F; Mei C; Westphal H; Germino GG
J Am Soc Nephrol; 2004 Dec; 15(12):3035-43. PubMed ID: 15579506
[TBL] [Abstract][Full Text] [Related]
40. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
